Author
Listed:
- Xin Hu
(The University of Texas MD Anderson Cancer Center)
- Marcos R. Estecio
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Runzhe Chen
(The University of Texas MD Anderson Cancer Center)
- Alexandre Reuben
(The University of Texas MD Anderson Cancer Center)
- Linghua Wang
(The University of Texas MD Anderson Cancer Center)
- Junya Fujimoto
(The University of Texas MD Anderson Cancer Center)
- Jian Carrot-Zhang
(Broad Institute of MIT and Harvard
Dana-Farber Cancer Institute
Harvard Medical School)
- Nicholas McGranahan
(Cancer Research United Kingdom-University College London Lung Cancer Centre of Excellence)
- Lisha Ying
(Chinese Academy of Sciences
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital))
- Junya Fukuoka
(Nagasaki University Graduate School of Biomedical Sciences)
- Chi-Wan Chow
(The University of Texas MD Anderson Cancer Center)
- Hoa H. N. Pham
(Nagasaki University Graduate School of Biomedical Sciences)
- Myrna C. B. Godoy
(The University of Texas MD Anderson Cancer Center)
- Brett W. Carter
(The University of Texas MD Anderson Cancer Center)
- Carmen Behrens
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Jianhua Zhang
(The University of Texas MD Anderson Cancer Center)
- Mara B. Antonoff
(The University of Texas MD Anderson Cancer Center)
- Boris Sepesi
(The University of Texas MD Anderson Cancer Center)
- Yue Lu
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- Harvey I. Pass
(New York University Langone Medical Center)
- Humam Kadara
(The University of Texas MD Anderson Cancer Center)
- Paul Scheet
(The University of Texas MD Anderson Cancer Center)
- Ara A. Vaporciyan
(The University of Texas MD Anderson Cancer Center)
- John V. Heymach
(The University of Texas MD Anderson Cancer Center)
- Ignacio I. Wistuba
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
- J. Jack Lee
(The University of Texas MD Anderson Cancer Center)
- P. Andrew Futreal
(The University of Texas MD Anderson Cancer Center)
- Dan Su
(Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital))
- Jean-Pierre J. Issa
(Coriell Institute for Medical Research)
- Jianjun Zhang
(The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center)
Abstract
The evolution of DNA methylome and methylation intra-tumor heterogeneity (ITH) during early carcinogenesis of lung adenocarcinoma has not been systematically studied. We perform reduced representation bisulfite sequencing of invasive lung adenocarcinoma and its precursors, atypical adenomatous hyperplasia, adenocarcinoma in situ and minimally invasive adenocarcinoma. We observe gradual increase of methylation aberrations and significantly higher level of methylation ITH in later-stage lesions. The phylogenetic patterns inferred from methylation aberrations resemble those based on somatic mutations suggesting parallel methylation and genetic evolution. De-convolution reveal higher ratio of T regulatory cells (Tregs) versus CD8 + T cells in later-stage diseases, implying progressive immunosuppression with neoplastic progression. Furthermore, increased global hypomethylation is associated with higher mutation burden, copy number variation burden and AI burden as well as higher Treg/CD8 ratio, highlighting the potential impact of methylation on chromosomal instability, mutagenesis and tumor immune microenvironment during early carcinogenesis of lung adenocarcinomas.
Suggested Citation
Xin Hu & Marcos R. Estecio & Runzhe Chen & Alexandre Reuben & Linghua Wang & Junya Fujimoto & Jian Carrot-Zhang & Nicholas McGranahan & Lisha Ying & Junya Fukuoka & Chi-Wan Chow & Hoa H. N. Pham & Myr, 2021.
"Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas,"
Nature Communications, Nature, vol. 12(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-20907-z
DOI: 10.1038/s41467-021-20907-z
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-20907-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.